EE10 Cost-Effectiveness of Pembrolizumab Plus Chemotherapies for First-Line Treatment in Locally Advanced Unresectable or Metastatic Triple Negative Breast Cancer (MTNBC) in France

Abstract

Authors

O Tredan L Bensimon M Apert B Tehard M Carita A Khandelwal J Gandhi A Haiderali M Huang P Levy